Diabetes medication may lower heart attack and stroke risk by curbing platelet overactivation
For millions living with type 2 diabetes, heart disease remains one of the greatest threats to their health.
Oct 28, 2026
0
19
Organic Chemical: empagliflozin
Medical news and research articles
Popular diabetes drug shown to lower inflammation, which may protect the heart
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown to reduce inflammatory ...
Oct 6, 2026
0
23
Lab-grown tissue reveals how inflammation may drive heart relaxation failure
Scientists study the underlying causes of a disease or test potential new drugs in animal models or cells obtained from human biopsy specimens before clinical trials. However, disease models in animals do not mimic actual ...
Sep 2, 2026
0
8
Patient data show diabetes medicine could save thousands more lives a year
Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study led by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) and UCL. Using ...
Feb 10, 2026
0
16
New TrumpRx site aims to cut drug costs for popular prescription drugs
The Trump administration has rolled out a new website called TrumpRx, aimed at offering consumers lower prices on certain prescription drugs. The site, launched last week, lists discounted medications from more than a dozen ...
Feb 9, 2026
0
6
Dozens of states tackle high prescription drug costs
In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit.
Nov 4, 2025
0
15
New trial finds diabetes drug and nasal insulin improve brain health in early Alzheimer's disease
A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes drug empagliflozin (Jardiance) and intranasal insulin, safely improve brain health in people with mild ...
Oct 16, 2025
0
26
Evidence appears supportive for the initiation of SGLT2 inhibitors in patients hospitalized for heart failure
In-hospital initiation of dapagliflozin did not significantly reduce the short-term risk of cardiovascular death or worsening heart failure (HF) in patients admitted for HF, although positive effects were seen when combining ...
Sep 1, 2025
0
16
Empagliflozin has kidney protective effects in acute myocardial infarction
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published online June 13 in Nature ...
Jun 26, 2025
0
46
Ozempic outperforms another diabetes drug for reducing stroke risk
Type 2 diabetes patients taking semaglutide, often sold as Ozempic or Wegovy, have a slightly lower risk of stroke compared to patients taking another diabetes drug—empagliflozin. International researchers studied data from ...
Jun 17, 2025
0
24
